← back to search

Frank Bennett

Johns Hopkins Medicine · US
🔎 Find collaborators in Hepatology · Infectious Diseases →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Hepatology · Infectious Diseases
Research interest
Research focused on Amyotrophic lateral sclerosis and Nuclear pore, with related work in Scrapie, C9orf72, Biomarker. Notable publications include 'Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS', 'Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice', and 'G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons'.
h-index
citations
317
works
7
NIH funding
primary concept
email

Recent publications

G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons
Acta Neuropathologica 2023cited by 37position: middledoi
Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice
Annals of Neurology 2023cited by 36position: middledoi
Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1
Human Gene Therapy 2022cited by 22position: middledoi
Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS
Science Translational Medicine 2021cited by 141position: middledoi
An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosis
JCI Insight 2019cited by 20position: middledoi
Reliability of functional outcome measures in spinal muscular atrophy: Results from multi-centered, global, phase 3 clinical trials (S13.004)
Neurology 2017cited by 1position: middledoi
Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice
Molecular Therapy — Nucleic Acids 2012cited by 60position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Frank Rigo · Ionis Pharmaceuticals (United States)4 papers (2019–2023)Joanne Wuu · University of Miami2 papers (2019–2023)Victoria Baskerville · Johns Hopkins Medicine2 papers (2021–2023)Michael Benatar · University of Miami2 papers (2019–2023)Alyssa N. Coyne · Johns Hopkins Medicine2 papers (2021–2023)Jeffrey D. Rothstein · German Center for Neurodegenerative Diseases2 papers (2021–2023)Lucie Bruijn · Barrow Neurological Institute1 papers (2023–2023)Thiéry De Serres‐Bérard · Université Laval1 papers (2022–2022)Pierre Lessard · Hôpital régional1 papers (2012–2012) · 1 papers (2012–2012)Mohamed Chahine · New York University1 papers (2022–2022)Dennis W. Dickson · Mayo Clinic1 papers (2021–2021)Jeremy M. Shefner · Mayo Clinic in Florida1 papers (2023–2023)Jacqueline Montes · Columbia University Irving Medical Center1 papers (2017–2017)Mohamed Boutjdir · SUNY Downstate Health Sciences University1 papers (2022–2022)Sina Ghaemmaghami · University of Rochester1 papers (2012–2012)Lyle W. Ostrow · Temple University1 papers (2023–2023)Allan M. Glanzman · Columbia University1 papers (2017–2017)Timothy M. Miller · Boston Children's Hospital1 papers (2019–2019)Majid Ghassemian · University of California San Diego1 papers (2019–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Hepatology · Infectious Diseases →